VWR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
VWR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
VWR's average Accounts Receivable for the three months ended in Sep. 2017 was $684 Mil. VWR's Revenue for the three months ended in Sep. 2017 was $1,195 Mil. Hence, VWR's Days Sales Outstanding for the three months ended in Sep. 2017 was 52.25.
The historical rank and industry rank for VWR's Days Sales Outstanding or its related term are showing as below:
VWR's Days Sales Outstanding increased from Sep. 2016 (51.03) to Sep. 2017 (52.25).
The historical data trend for VWR's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VWR Annual Data | |||||||||||||||
Trend | Dec11 | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | |||||||||
Days Sales Outstanding | Get a 7-Day Free Trial | 52.76 | 51.53 | 48.76 | 49.30 | 48.13 |
VWR Quarterly Data | ||||||||||||||||||||
Dec12 | Mar13 | Jun13 | Sep13 | Dec13 | Mar14 | Jun14 | Sep14 | Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | |
Days Sales Outstanding | Get a 7-Day Free Trial | 51.03 | 50.00 | 50.70 | 51.88 | 52.25 |
For the Diagnostics & Research subindustry, VWR's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, VWR's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where VWR's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Accounts Receivable can be measured by Days Sales Outstanding.
VWR's Days Sales Outstanding for the fiscal year that ended in Dec. 2016 is calculated as
Days Sales Outstanding (A: Dec. 2016 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Dec. 2015 ) | + | Accounts Receivable (A: Dec. 2016 )) | / | count ) | / | Revenue (A: Dec. 2016 ) | * | Days in Period |
= | ( (583.2 | + | 607.2) | / | 2 ) | / | 4514.2 | * | 365 |
= | 595.2 | / | 4514.2 | * | 365 | ||||
= | 48.13 |
VWR's Days Sales Outstanding for the quarter that ended in Sep. 2017 is calculated as:
Days Sales Outstanding (Q: Sep. 2017 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Jun. 2017 ) | + | Accounts Receivable (A: Sep. 2017 )) | / | count ) | / | Revenue (A: Sep. 2017 ) | * | Days in Period |
= | ( (677.6 | + | 691.1) | / | 2 ) | / | 1195.2 | * | 365 / 4 |
= | 684.35 | / | 1195.2 | * | 365 / 4 | ||||
= | 52.25 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VWR (NAS:VWR) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Thank you for viewing the detailed overview of VWR's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Madison Dearborn Partners Llc | 10 percent owner | THREE FIRST NATIONAL PLAZA, 70 WEST MADISON STREET, SUITE 4600, CHICAGO IL 60602 |
Gregory L Cowan | officer: See remarks | 1717 ARCH STREET, 35TH FLOOR, PHILADELPHIA PA 19103 |
Edward A Blechschmidt | director | ONE HEALTHSOUTH PARKWAY, BIRMINGHAM AL 35243 |
Douglas J. Pitts | officer: See remarks | 100 MATSONFORD ROAD, RADNOR PA 19087 |
Pamela Forbes Lieberman | director | 3400 N.WOLF ROAD, FRANKLIN PARK IL 60131 |
Robert Zollars | director | 3061 ZANKER RD, SAN JOSEC CA 95134 |
Timothy P Sullivan | director, 10 percent owner | THREE FIRST NATIONAL PLZ, SUITE 3800, CHICAGO IL 60602 |
Nicholas W Alexos | director, 10 percent owner | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Kraemer Harry M Jansen Jr | director | DENTSPLY SIRONA INC., 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Madison Dearborn Partners V-a&c, L.p. | 10 percent owner | THREE FIRST NATIONAL PLAZA, SUITE 3800, CHICAGO IL 60602 |
Madison Dearborn Capital Partners V Executive-a L P | 10 percent owner | THREE FIRST NATIONAL PLAZA, SUITE 3800, CHICAGO IL 60602 |
Madison Dearborn Capital Partners V - C L P | 10 percent owner | THREE FIRST NATIONAL PLAZA, SUITE 3800, CHICAGO IL 60602 |
Madison Dearborn Capital Partners V - A L P | 10 percent owner | THREE FIRST NATIONAL PLAZA, SUITE 4600, CHICAGO IL 60602 |
Samuel M Mencoff | 10 percent owner | BUCKEYE TECHNOLOGIES INC, 1001 TILLMAN STREET, MEMPHIS TN 38112 |
Paul J Finnegan | 10 percent owner | PO BOX 2000, 3905 DAKOTA STREET SW, ALEXANDRIA MN 56308 |
From GuruFocus
By Tiziano Frateschi Tiziano Frateschi • 02-09-2018
By Tiziano Frateschi Tiziano Frateschi • 05-27-2016
By PRNewswire PRNewswire • 08-15-2018
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.